Capitol Historical Income Statement

CAJ Stock

0.37 0.01 2.78%

Historical analysis of Capitol Health income statement accounts such as Selling General Administrative of 163.1 M, Total Revenue of 246.6 M or Cost Of Revenue of 199.6 M can show how well Capitol Health performed in making a profits. Evaluating Capitol Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Capitol Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Capitol Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Capitol Health is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Capitol Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Capitol Income Statement Analysis

Capitol Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Capitol Health shareholders. The income statement also shows Capitol investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Capitol Health Income Statement Chart

At this time, Capitol Health's Discontinued Operations is comparatively stable compared to the past year. Tax Provision is likely to gain to about 3.3 M in 2024, whereas EBITDA is likely to drop slightly above 16 M in 2024.

Selling General Administrative Total Revenue Cost Of Revenue Selling And Marketing Expenses Income Tax Expense Minority Interest

Total Revenue

Total revenue comprises all receipts Capitol Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Cost Of Revenue

Cost of Revenue is found on Capitol Health income statement and represents the costs associated with goods and services Capitol Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Minority Interest

Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Capitol Health whose combined shares represent less than 50% of the total outstanding shares issued by Capitol Health have a minority interest in Capitol Health.

Most accounts from Capitol Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Capitol Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Capitol Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Cost Of Revenue	145.9M	172.4M	190.1M	199.6M
Total Revenue	184.2M	209.6M	234.8M	246.6M

Cost Of Revenue Total Revenue

Capitol Health income statement Correlations

	Interest Expense	Selling General Administrative	Total Revenue	Cost Of Revenue	Depreciation And Amortization	Selling And Marketing Expenses	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Discontinued Operations	Net Income From Continuing Ops	Tax Provision	Interest Income	Net Interest Income	Extraordinary Items	Reconciled Depreciation	Minority Interest
Interest Expense		0.81	0.85	0.86	0.79	0.83	0.39	0.89	0.69	-0.45	0.24	0.15	-0.6	-0.55	-0.66	0.12	0.73	-0.75	-0.22	0.09	0.01	0.73	0.68	-0.59
Selling General Administrative	0.81		0.9	0.89	0.91	0.99	0.49	0.89	0.77	-0.16	0.55	-0.07	-0.21	-0.28	-0.28	0.35	0.93	-0.32	0.09	-0.08	0.28	0.93	0.86	-0.69
Total Revenue	0.85	0.9		0.99	0.91	0.91	0.58	0.99	0.86	-0.05	0.63	-0.01	-0.19	-0.36	-0.28	0.44	0.82	-0.41	-0.01	-0.13	0.25	0.82	0.82	-0.68
Cost Of Revenue	0.86	0.89	0.99		0.92	0.93	0.46	0.98	0.83	-0.08	0.61	-0.13	-0.21	-0.35	-0.3	0.4	0.83	-0.42	-0.05	-0.1	0.27	0.83	0.83	-0.69
Depreciation And Amortization	0.79	0.91	0.91	0.92		0.91	0.43	0.91	0.75	-0.09	0.68	-0.1	-0.25	-0.31	-0.34	0.33	0.83	-0.4	0.01	-0.14	0.24	0.83	0.97	-0.67
Selling And Marketing Expenses	0.83	0.99	0.91	0.93	0.91		0.42	0.9	0.79	-0.16	0.56	-0.15	-0.2	-0.29	-0.27	0.37	0.95	-0.33	0.06	-0.06	0.33	0.95	0.85	-0.69
Gross Profit	0.39	0.49	0.58	0.46	0.43	0.42		0.57	0.6	0.24	0.51	0.61	0.09	-0.19	0.0	0.51	0.38	-0.11	0.21	-0.2	0.12	0.38	0.39	-0.29
Other Operating Expenses	0.89	0.89	0.99	0.98	0.91	0.9	0.57		0.83	-0.12	0.58	0.05	-0.28	-0.39	-0.37	0.38	0.81	-0.5	-0.08	-0.06	0.23	0.81	0.81	-0.69
Operating Income	0.69	0.77	0.86	0.83	0.75	0.79	0.6	0.83		0.26	0.72	-0.01	0.04	-0.45	-0.11	0.78	0.75	-0.21	0.41	-0.28	0.17	0.75	0.67	-0.49
Ebit	-0.45	-0.16	-0.05	-0.08	-0.09	-0.16	0.24	-0.12	0.26		0.65	-0.15	0.89	0.06	0.81	0.76	-0.04	0.73	0.64	-0.43	0.37	-0.04	-0.06	0.22
Ebitda	0.24	0.55	0.63	0.61	0.68	0.56	0.51	0.58	0.72	0.65		-0.17	0.46	-0.14	0.34	0.79	0.6	0.24	0.44	-0.36	0.48	0.6	0.71	-0.33
Total Operating Expenses	0.15	-0.07	-0.01	-0.13	-0.1	-0.15	0.61	0.05	-0.01	-0.15	-0.17		-0.33	-0.2	-0.35	-0.12	-0.15	-0.39	-0.2	0.29	-0.23	-0.15	-0.13	0.03
Income Before Tax	-0.6	-0.21	-0.19	-0.21	-0.25	-0.2	0.09	-0.28	0.04	0.89	0.46	-0.33		0.31	0.98	0.58	-0.06	0.94	0.55	-0.36	0.51	-0.06	-0.21	0.34
Total Other Income Expense Net	-0.55	-0.28	-0.36	-0.35	-0.31	-0.29	-0.19	-0.39	-0.45	0.06	-0.14	-0.2	0.31		0.39	-0.22	-0.23	0.46	-0.1	0.23	0.28	-0.23	-0.22	0.33
Net Income	-0.66	-0.28	-0.28	-0.3	-0.34	-0.27	0.0	-0.37	-0.11	0.81	0.34	-0.35	0.98	0.39		0.44	-0.13	0.96	0.45	-0.29	0.51	-0.13	-0.3	0.4
Income Tax Expense	0.12	0.35	0.44	0.4	0.33	0.37	0.51	0.38	0.78	0.76	0.79	-0.12	0.58	-0.22	0.44		0.42	0.36	0.76	-0.49	0.31	0.42	0.32	-0.11
Discontinued Operations	0.73	0.93	0.82	0.83	0.83	0.95	0.38	0.81	0.75	-0.04	0.6	-0.15	-0.06	-0.23	-0.13	0.42		-0.19	0.07	0.11	0.52	1.0	0.79	-0.52
Net Income From Continuing Ops	-0.75	-0.32	-0.41	-0.42	-0.4	-0.33	-0.11	-0.5	-0.21	0.73	0.24	-0.39	0.94	0.46	0.96	0.36	-0.19		0.52	-0.33	0.44	-0.19	-0.34	0.41
Tax Provision	-0.22	0.09	-0.01	-0.05	0.01	0.06	0.21	-0.08	0.41	0.64	0.44	-0.2	0.55	-0.1	0.45	0.76	0.07	0.52		-0.7	-0.04	0.07	0.05	0.04
Interest Income	0.09	-0.08	-0.13	-0.1	-0.14	-0.06	-0.2	-0.06	-0.28	-0.43	-0.36	0.29	-0.36	0.23	-0.29	-0.49	0.11	-0.33	-0.7		0.21	0.11	-0.13	0.13
Net Interest Income	0.01	0.28	0.25	0.27	0.24	0.33	0.12	0.23	0.17	0.37	0.48	-0.23	0.51	0.28	0.51	0.31	0.52	0.44	-0.04	0.21		0.52	0.23	0.01
Extraordinary Items	0.73	0.93	0.82	0.83	0.83	0.95	0.38	0.81	0.75	-0.04	0.6	-0.15	-0.06	-0.23	-0.13	0.42	1.0	-0.19	0.07	0.11	0.52		0.79	-0.52
Reconciled Depreciation	0.68	0.86	0.82	0.83	0.97	0.85	0.39	0.81	0.67	-0.06	0.71	-0.13	-0.21	-0.22	-0.3	0.32	0.79	-0.34	0.05	-0.13	0.23	0.79		-0.64
Minority Interest	-0.59	-0.69	-0.68	-0.69	-0.67	-0.69	-0.29	-0.69	-0.49	0.22	-0.33	0.03	0.34	0.33	0.4	-0.11	-0.52	0.41	0.04	0.13	0.01	-0.52	-0.64

Click cells to compare fundamentals

Capitol Health Account Relationship Matchups

Capitol Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	3.7M	3.4M	2.9M	5.2M	7.8M	8.2M
Selling General Administrative	96.0M	107.0M	119.4M	141.1M	155.3M	163.1M
Total Revenue	153.8M	178.0M	184.2M	209.6M	234.8M	246.6M
Cost Of Revenue	126.7M	133.4M	145.9M	172.4M	190.1M	199.6M
Depreciation And Amortization	26.0M	21.4M	21.1M	24.7M	27.1M	28.4M
Selling And Marketing Expenses	79.2M	89.1M	101.1M	119.3M	132.8M	139.5M
Gross Profit	27.1M	44.6M	38.3M	37.2M	44.7M	34.6M
Other Operating Expenses	143.5M	151.4M	164.1M	194.1M	212.6M	223.2M
Operating Income	10.3M	26.6M	20.1M	15.4M	22.2M	23.3M
Ebit	5.9M	22.8M	20.1M	(4.9M)	(3.7M)	(3.5M)
Ebitda	31.9M	44.2M	41.1M	19.8M	23.4M	16.0M
Total Operating Expenses	16.8M	17.9M	18.2M	21.8M	22.5M	18.0M
Income Before Tax	2.2M	19.4M	15.9M	(10.1M)	(11.5M)	(10.9M)
Total Other Income Expense Net	(8.2M)	(7.2M)	(25.2M)	21.7M	(33.7M)	(32.0M)
Net Income	865K	11.9M	10.7M	(11.4M)	(14.9M)	(14.1M)
Income Tax Expense	1.1M	7.4M	5.0M	1.2M	3.3M	2.2M
Net Income Applicable To Common Shares	865K	11.9M	10.7M	(11.4M)	(13.1M)	(12.4M)
Net Income From Continuing Ops	1.1M	12.0M	11.0M	(11.3M)	(14.8M)	(14.0M)
Tax Provision	1.1M	7.4M	5.0M	1.2M	3.3M	3.3M
Interest Income	3.4M	13K	1.1M	4.1M	474K	450.3K
Net Interest Income	(3.2M)	(3.4M)	(2.9M)	(4.9M)	(7.4M)	(7.0M)
Reconciled Depreciation	26.0M	21.4M	21.1M	24.7M	27.1M	19.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Capitol Stock Analysis

When running Capitol Health's price analysis, check to measure Capitol Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capitol Health is operating at the current time. Most of Capitol Health's value examination focuses on studying past and present price action to predict the probability of Capitol Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Capitol Health's price. Additionally, you may evaluate how the addition of Capitol Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC